Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MLNK | Common Stock, par value $0.001 | Options Exercise | $38.7K | +6.39K | +2.37% | $6.06 | 276K | Jan 3, 2023 | Direct | F1 |
transaction | MLNK | Common Stock, par value $0.001 | Sale | -$153K | -10.9K | -3.95% | $14.02 | 265K | Jan 3, 2023 | Direct | F1, F2 |
transaction | MLNK | Common Stock, par value $0.001 | Options Exercise | $153K | +25.3K | +9.54% | $6.06 | 290K | Jan 4, 2023 | Direct | F1 |
transaction | MLNK | Common Stock, par value $0.001 | Sale | -$436K | -30.9K | -10.64% | $14.10 | 259K | Jan 4, 2023 | Direct | F1, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MLNK | Stock Option (option to buy) | Options Exercise | $0 | -6.39K | -4.73% | $0.00 | 129K | Jan 3, 2023 | Common Stock, par value $0.001 | 6.39K | $6.06 | Direct | F1, F4 |
transaction | MLNK | Stock Option (option to buy) | Options Exercise | $0 | -25.3K | -19.66% | $0.00 | 103K | Jan 4, 2023 | Common Stock, par value $0.001 | 25.3K | $6.06 | Direct | F1, F4 |
Id | Content |
---|---|
F1 | This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 28, 2022. |
F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.10, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.33, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F4 | With respect to (i) 75,000 of the shares underlying the option, 75% of such shares vested upon the Issuer's achievement of a predetermined EBITDA metric on each of December 31, 2019, 2020, and 2021, and the remaining 25% of such shares are scheduled to vest based upon the Issuer's level of achievement of a predetermined EBITDA metric for 2022; and (ii) 60,000 of the shares underlying the option, 25% of such shares vested on October 14, 2020, and the remaining 75% of such shares vest in 36 equal monthly instalments thereafter, in each case subject to the reporting person's continued service through the applicable vesting date. |